Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for Hydroxocobalamin Injection.

date
11:55 14/01/2025
avatar
GMT Eight
Yipinhong (300723.SZ) announcement, the company's wholly-owned subsidiary Guangzhou Yipinhong Pharmaceutical Co., Ltd. recently received national...
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Group Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Mecobalamin Injection. Mecobalamin Injection is indicated for the treatment of peripheral neuropathy and megaloblastic anemia caused by vitamin B12 deficiency.